Biotech Values

[poorgradstudent]

HGSI

They actually have a collaboration with GSK on an LP-PLA2 drug that is called darapladib. This is what first drew my attention to HGSI many many years ago. LP-PLA2 can be a risk factor for cardiovascular disease, but whether it is a causative factor is the big question that has not been solved. When I last checked, GSK had just decided to move it into phase III, so the day of reckoning is still a ways away.